The markets opened lower with the Dow slipping 5 points to 20,657 after the U.S. launched missiles at a Syrian airfield. Nasdaq lost 7 points to 5,871.
On the upside
Cleantech Solutions International (Nasdaq: CLNT) regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement.
Bargain hunters lifted shares of MannKind (Nasdaq: MNKD).
Aurinia Pharmaceuticals (Nasdaq: AUPH) announced details for a global Phase III AURORA trial.
On the downside
Catalyst Biosciences (Nasdaq: CBIO) priced its public offering of Class A and Class B units.
DryShips (Nasdaq: DRYS) announced a 1-for-4 reverse stock split that will take effect at market open on April 11, 2017.
Investors locked in profits on HTG Molecular (Nasdaq: HTGM).
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE while decliners edged out advancers by 8 to 5 on Nasdaq. The broader S&P 500 index slipped 2 points to 2,354. Bitcoin fell $4 to $1183.
